| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.00072 | 1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.00076 | 1 |